These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15898148)

  • 21. Ximelagatran. Exanta, H 376, H 376/95, H 37695.
    Drugs R D; 2002; 3(6):431-4. PubMed ID: 12516951
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Tandoğan I
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):216; author reply 218-9. PubMed ID: 17513230
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Kiraç FS
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):214-5; author reply 218-9. PubMed ID: 17513229
    [No Abstract]   [Full Text] [Related]  

  • 24. The beginning of the end of warfarin?
    Eikelboom JW; Hankey GJ
    Med J Aust; 2004 Jun; 180(11):549-51. PubMed ID: 15174982
    [No Abstract]   [Full Text] [Related]  

  • 25. How can 'Hy's law' help the clinician?
    Senior JR
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):235-9. PubMed ID: 16552792
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ximelagatran: a new type of oral anticoagulant.
    Kwok L; Molckovsky D; Boucher M
    Int J Technol Assess Health Care; 2005; 21(4):480-6. PubMed ID: 16262971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct thrombin inhibitors - a survey of recent developments.
    Schwienhorst A
    Cell Mol Life Sci; 2006 Dec; 63(23):2773-91. PubMed ID: 17103113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hy's law: predicting serious hepatotoxicity.
    Temple R
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):241-3. PubMed ID: 16552790
    [No Abstract]   [Full Text] [Related]  

  • 31. A profit-thinner. Hospitals, docs await substitute for risky warfarin.
    Becker C
    Mod Healthc; 2005 Jul; 35(30):32-3. PubMed ID: 16101253
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trials and tribulations of non-inferiority: the ximelagatran experience.
    Kaul S; Diamond GA; Weintraub WS
    J Am Coll Cardiol; 2005 Dec; 46(11):1986-95. PubMed ID: 16325029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ximelagatran for stroke prevention in atrial fibrillation.
    Boos CJ; Lip GY
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):551-63. PubMed ID: 16076267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trials and tribulations of noninferiority: the ximelagatran experience.
    Albers GW; Diener HC; Frison L; Grind M; Horrow J; Nevinson M; Olsson SB; Partridge S; Petersen P; Vahanian A; Halperin JL;
    J Am Coll Cardiol; 2006 Sep; 48(5):1058; author reply 1059. PubMed ID: 16949503
    [No Abstract]   [Full Text] [Related]  

  • 36. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current anticoagulation therapy--a GP guide.
    Tan KT; Lip GY
    Practitioner; 2004 Feb; 248(1655):87-8, 92-4, 97-8. PubMed ID: 15008109
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 40. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.